Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros












Base de dados
Intervalo de ano de publicação
1.
Bioorg Med Chem Lett ; 102: 129670, 2024 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-38387692

RESUMO

Histone deacetylase 6 (HDAC6) has drawn more and more attention for its potential application in Alzheimer's disease (AD) therapy. A series of tetrahydro-ß-carboline (THßC) hydroxamic acids with aryl linker were synthesized. In enzymatic assay, all compounds exhibited nanomolar IC50 values. The most promising compound 11d preferentially inhibited HDAC6 (IC50, 8.64 nM) with approximately 149-fold selectivity over HDAC1. Molecular simulation revealed that the hydroxamic acid of 11d could bind to the zinc ion by a bidentate chelating manner. In vitro, 11d induced neurite outgrowth of PC12 cells without producing toxic effects and showed obvious neuroprotective activity in a model of H2O2-induced oxidative stress.


Assuntos
Carbolinas , Inibidores de Histona Desacetilases , Peróxido de Hidrogênio , Ratos , Animais , Desacetilase 6 de Histona , Inibidores de Histona Desacetilases/farmacologia , Peróxido de Hidrogênio/farmacologia , Ácidos Hidroxâmicos/farmacologia , Crescimento Neuronal , Histona Desacetilase 1/metabolismo , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...